WO1998030279A1 - An implantable nerve stimulator electrode - Google Patents

An implantable nerve stimulator electrode Download PDF

Info

Publication number
WO1998030279A1
WO1998030279A1 PCT/DK1998/000010 DK9800010W WO9830279A1 WO 1998030279 A1 WO1998030279 A1 WO 1998030279A1 DK 9800010 W DK9800010 W DK 9800010W WO 9830279 A1 WO9830279 A1 WO 9830279A1
Authority
WO
WIPO (PCT)
Prior art keywords
stimulator
electrode
nerve bundle
nerve
coupled
Prior art date
Application number
PCT/DK1998/000010
Other languages
French (fr)
Inventor
Morten Haugland
Hans Harding
Original Assignee
Neurodan A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurodan A/S filed Critical Neurodan A/S
Priority to US09/331,838 priority Critical patent/US6366815B1/en
Priority to AU54782/98A priority patent/AU5478298A/en
Priority to DE69825969T priority patent/DE69825969T2/en
Priority to AT98900271T priority patent/ATE274974T1/en
Priority to EP98900271A priority patent/EP0948373B1/en
Publication of WO1998030279A1 publication Critical patent/WO1998030279A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36125Details of circuitry or electric components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • A61N1/0556Cuff electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The invention relates to an implantable stimulator electrode for stimulation of nerves adapted to be surgically implanted around a nerve bundle, said stimulator comprising one or more electrode means which, when implanted around said nerve bundle, surrounds the nerve bundle totally or partly. Electrode means and electronic circuit means are coupled to and powered by one or more receiving coils mounted on the stimulator housing. One advantage of the invention is that the electrode, when implanted, acts as a remote addressable maintenance free unit.

Description

AN IMPLANTABLE NERVE STIMULATOR ELECTRODE
Background of the invention
The invention relates to an implantable electrode for stimulation of nerves adapted to be surgically implanted around a nerve bundle.
Restoring motor-functions of (partially) paralysed people is known by exploiting the fact that muscles respond to electrical energy. This principle can be utilised to directly stimulate muscles or to stimulate the nerves leading to the muscles. Direct stimulation of muscles requires a number of electrodes distributed on the muscle, compare e.g. US-A 5,314,458, and is relatively power con- suming. In addition, the control equipment is rather complicated for surveillance of the electrodes to achieve the desired movement of the muscle.
Stimulation of nerves can be made by placing electrodes locally around the nerves which is known from e.g. US-A 5,038,781. For this reason the surgical intervention is minor. Stimulation of nerves also requires much less energy than stimulation of muscles although the power requirement is still high compared to e.g. a pacemaker due to the higher stimulation frequency necessary to obtain smooth contractions of muscles. The present invention relates to nerve stimulation.
The controlling equipment and the power supply are placed externally on the human body and could be connected to the electrodes by using wires passing through the skin which for obvious reasons is not an attractive solution. Alternatively, the placement of a transmitter on the body and an implant of a receiver in the body wired to the electrodes is also known, said transmitter sending signals and energy through the skin and flesh to the receiver. More specifically, the present invention relates to the latter type of stimulator electrodes.
Such a neurological stimulation apparatus is known from e.g. US-A 5,038,781 said apparatus comprising nerve cuffs with electrodes attached to a nerve bundle and wire connected to an implant case containing the electronic cir- cuitry receiving operating power and information signals by radio frequency coupling to an external unit. Running wires under the skin and implanting a casing in the body is for obvious reasons not an attractive solution.
Another example is known from US-A 4,057,069 which deals with an implantable nerve stimulator receiving energy from an external unit by telemetrically transferring en¬ ergy from an external unit. The nerve stimulator contains a detector circuit which by an adequate excitation can address a number of electrode pairs of a multiplexer. The nerve stimulator has among other things the disadvantage in connection with multielectrode systems of not being able to address all of these simultaneously, however, only sequentially. In addition, the nerve stimulator is limited locally, as the electrode pairs in question necessarily have to be in galvanic contact with the nerve stimulator itself.
A further example is known from US patent no. 3,667,477 which deals with an implantable nerve stimulator which receives energy from an external unit by telemetric transmission. The implantation of the disclosed nerve stimulator, however, is quite complicated, as the stimu- lator is made of separate receiving and electrode means coupled by leads.
It could be mentioned that it is also known to stimulate muscles by means of telemetric transmission.
An example is known from US patent no. 5,314,458 which deals with an implantable muscle stimulator which receives energy from an external unit by telemetric trans- mission. This unit can be addressed individually, however, due to its placement on the muscle itself a very powerful excitation is needed and subsequently a very powerful electromagnetic field which causes the electromagnetic transfer of energy to be less attractive consid- ering the continuing influence of the surrounding tissue. In addition, it is needed that the stimulator is being widely controlled when stimulating a muscle complex, as a certain number of specific controlled stimulators is needed in order to obtain an appropriate movement of the muscle.
Summary of the invention
One object of the present invention is to provide an improved and simplified neurological stimulation apparatus. A further object is to minimise the surgical intervention when applying the apparatus in the body.
When according to the present invention the input terminals coupled to one or more receiving coils are mounted on the stimulator housing, a remote individual addressable stimulator for stimulation of nerve bundles is obtained thus being able to function as an isolated implanted unit. When implanted, the stimulator will be placed in a juxta position or around the nerve being stimulated. According to the invention there is no need for any lead connections between the stimulator and external circuits, in the sense that the transmitter can be activated on location by remote signals without any need for an internal power source.
The control of the stimulator or the stimulators and the resulting activation of muscles is made even more simple due to the fact that a stimulation of the nerve often is less complicated than a stimulation directly on the muscles which are to be activated. In the case when a group of muscles or a muscle with multiple motor points innervated by the same nerve are wished to be activated at the same time (as for example in the case of dropfoot stimu- lation) , it is advantageous to use one multichannel nerve stimulator placed on the nerve compared to many individual stimulators placed in the muscles.
According to the invention it is thus possible to obtain a remote stimulation using a minimal electromagnetic field.
Coupling the input terminals to one or more receiving coils mounted on the stimulator/electrode housing, it is possible to obtain a necessary power supply to the electrodes and the electronic circuit means which is provided telemetrically via the receiving coil or receiving coils, thus avoiding the use of lead connections between the internal part of the stimulator and the external part of the stimulator. It is thus possible to avoid battery powered electrodes. Furthermore, the transmitter is basically free of maintenance in the sense that replacement of implanted power sources or the like is not needed.
In this connection, it is noted that the necessary effect needed to stimulate the nerves is approximately ten times lower than the necessary effect needed for direct stimulation of muscles. By stimulating the nerves rather than the muscles, a remote activation of the stimulator is particularly attractive.
The risk of complications due to the surgery activity required to implant the stimulator is moreover reduced in the sense that the stimulator itself, according to the invention, can be realised in a very compact design in contrary to e.g. lead-connected systems.
The stimulator according to the invention is especially applicable in situations where a continuing or periodi- cally stimulation of the muscle is needed, as the implanted stimulator under constant influence of movement is mechanically as well as electronically stable and sturdy in the sense that neither the electrical nor the mechanical parts undergo stress during said movement which also results in a minimised risk of IN VIVO complications .
In addition, the use of an external power source will in practise result in a minimised risk of noise signals ac- tivating the stimulator as these external noise signals necessarily have to reach a certain noise level at a given wavelength in order to activate the electrodes of the stimulator. Accordingly, in a further embodiment of the invention, the electrode means, when implanted around said nerve bundle, comprises one or more circle-shaped or semi- circumferential electrodes defining a contact area, each contact area being electrically coupled to the output terminals of the electronic circuit means. (Totally or partly surrounding the output terminals) . This particular "shape" of the electrode means thus makes it possible to obtain a very well-defined positioning of the stimulator as regards the nerve bundle and at the same time, the electrode means create good contact between the electrode means and the nerve bundle.
When the electrode means, when implanted around said nerve bundle, comprises one or more ring-shaped electrodes totally or partly surrounding the nerve bundle, each ring-shaped electrode comprising at least two distinct electrode contact areas, each electrode area being electrically coupled to the output terminals of the elec- tronic circuit means, it is possible to obtain a stimulator which is able to make a selective stimulation of the nerve and the associated muscles. The stimulation of the nerves can be obtained in various ways depending on which result is wanted. The stimulation can thus be obtained by a mono- or multipolar electrical stimulation, the chosen ultipolar electrode stimulation being transverse, e.g. effected by electrodes on the same ring electrode or longitudinal, e.g. effected by electrodes on different rings. Furthermore, it is possible to combine transverse and longitudinal stimulation. The stimulator thus has the possibility of being used with an overall degree of selectivity which can be chosen from known mono- or multipolar configurations . In a multichannel stimulator, each channel has its own electronic circuit connected to a separate receiver coil. The only difference between each channel is the resonance frequency of which each channel is active. The main purpose of the electronic circuit is to create an adequate stimulation pulse shape.
When each transmitter comprises one or more transmitting coils positioned in spaced relationships on each side of one or more of the stimulators, it is possible to obtain a very useful remote activated stimulator system.
Brief description of the drawings Below, the invention will be further explained with ref¬ erence to the accompanying drawing, wherein
fig. 1 shows a stimulator according to the invention,
fig. 2 illustrates, by means of an electrical schematic diagram, a preferred embodiment of the receiver portion of the stimulator.
fig. 3 illustrates a two channel stimulator according to the invention,
fig. 4 shows a schematic drawing of a limb with stimulator and transmitter coils.
Description of a preferred embodiment
Referring to fig. 1 there is shown a stimulator according to the invention, said stimulator comprising a receiver coil 3 which is coupled to an electrical circuit 2. The electrical circuit 3 is furthermore connected to electrodes 6 and 7.
The electrode 6 is a feeding electrode coupled to one output terminal of the electrical circuit 3, while the electrodes 7 are return electrodes, coupled to the common output terminal of the electrical circuit.
The stimulator is encapsulated in a cuff made of a bio- logically inert substance 4 such as silicone rubber or the like. For placement of the cuff around a nerve, the cuff is slit length-wise in a zip-like manner.
The invention provides a very compact design of the stimulator by incorporating the receiving coil in the stimulator housing or stimulator body, and it is thus possible to implant the stimulator properly without the use of lead connection between co-operating stimulators or an external power supply.
Referring now to fig. 2, there is shown a preferred embodiment of the receiver portion of the stimulator.
The receiver portion of this embodiment includes a re- ceiver coil 10 in parallel with a capacitor 18 at junctions 32 and 31. The component values of the coil 10 and capacitor 18 are such that the circuit resonates at a selected receiver frequency.
A rectifier diode 11 is coupled to a filter capacitor 19 at a junction 33, which capacitor 19 is further connected to the common junction 32. The diode 11 rectifies an incoming signal and the filter capacitor 19 acts as a filter or bandpass filter for smoothing the signal and re- moving thigh frequency components of the rectified signal. Furthermore, a zenerdiode 22 is coupled in parallel with the capacitor 19.
A JFET transistor 11 is coupled between the junction 33 and junctions 34, 35, the latter being connected to the gate of the JFET 11. The JFET transistor 11 limits the current to between 1 to 2 mA which is a sufficient stimulation current.
A resistor 20 is coupled between the junctions 35 and 32. A diode 14 is followed by a capacitor 15 connects an electrode 16 to the junction 35, and a transistor 21 is coupled to the junctions 35, 36 and 32.
The common junction 32 is furthermore coupled to two electrodes 17.
The circuit following the current limiting transistor 12 has the primary function of balancing the charge fed to the electrodes/put out on the electrodes, as the stimulation of a nerve bundle will have to be without any DC- components ensuring that the nerves are not damaged by the injected charge. The balancing circuit, thus secures that the charge lead into the stimulated nerve equals the charge taken out from the nerve.
The stimulation current is controlled by a current lim- iter consisting of the J-FET T2. As there is a great manufacturing spread in the drain current of these, the units which when measured are found to have a drain current between 1 and 2mA are chosen. This circuit is principally sufficient when stimulating a nerve, however, since the nerve can be destroyed if only one polarity is stimulating the nerve, the pulses have to be charge balanced so that an equal amount of charge is drawn from the electrode as well as pumped into the electrode. This is ensured by the last part of the circuit. The transistor Tl is off as long as the transmitter is active. When the transmitter turns off, the voltage on Cl decreases which causes the base of Tl to be drawn low. While the pulse was sent, C3 was charged. This charge is now sent back through Tl which is on (D2 is blocking the other way) and backwards out through the electrode. As it is not possible to have a net DC current running through the capacitor (C3), a balanced stimulation is obtained ensuring that electro- chemical processes are not formed, which can destroy the tissue and the electrode. Zenerdiode Zl is a protection against too high a voltage in the circuit, which might be caused by interfering magnetic fields in the relevant frequence area. When the voltage is limited, a powerful lasting external field will not be able to cause anything else but a single pulse on the electrode with a charge of Qmax = VZ x C3 = 9, IV x 470nF = 4,3μC which in extreme cases can give a single powerful stimulation pulse which, however, is not damaging to the nerve nor the electrodes. The level of activation of the nerve/muscle is modulated by varying the pulse duration. The width of the pulse is variable by means of external transmitters e.g. between 0-255μs.
An external part of the stimulator, e.g. a corresponding telemetric transmitter (not shown) , is constructed by means of known electrical elements.
In a preferred embodiment according to the invention, the transmitter generates an electromagnetic burst of sine- waves of approximately 5MHz . The pulse is transmitted by two transmitting coils (shown in fig. 4) each made of six windings of copper wire with a diameter of 0.375 mm, the coil diameter being approximately 90 mm. The coils can be positioned in such a way, that the implanted stimulator is located in the homogeneous field created between the two transmitting coils.
The coils can for example be located or incorporated in different kinds of clothing, such as stockings, trousers or the like.
It should be noted that the electrical components wholly or partly may be manufactures in an integrated circuit, such as ASIC-designs or the like.
Moreover, it should be noted that the electrical environment of the electrodes in many applications preferably may be digital, as a coded multichannel remote signal is free of crosstalk between the channels.
Referring now to fig. 3, there is shown a stimulator according to the invention, said stimulator comprising a receiver coil 33, which is coupled to an electrical circuit 32. The electrical circuit 33 is furthermore con- nected to the dot electrodes 37, 38 and 39.
The stimulator further comprises a second receiver coil 43 which, in this embodiment, is coupled to a second electrical circuit 42. The second electrical circuit 43 is furthermore connected to the dot electrodes 47, 48 and 49.
The stimulator is thus a two channel stimulator with two separately operating receiving circuits, the circuits and the corresponding electrodes 31 and 41 being individually addressable. The electrodes are so-called dot-electrodes, which means that only a part of the ring-shaped electrode means is a electrode contact area in this embodiment. The stimulator is thus able to make a selective stimulation of the nerve and the associated muscles, when implanted around a nerve.
It is also possible within the scope of the invention to adapt the stimulator with several receiving channels. In one embodiment according to the invention the first receiving circuit is tuned to approximately 3.5 MHz and the second receiving circuit is tuned to approximately 4.7 MHz.
In fig. 4 is shown how the stimulator 50 in fig. 3 is mounted on the nerves 51 leading to the muscles 52 in a limb 53. As it is apparent from the drawing, two receiver coils 33 of the stimulator are placed parallel with the skin. The transmitter coils 54 are mounted in a bandage (not shown) placed around the limb. 55 designates the connection ends of the coils 54. The ends of the bandage are equipped with velcro-closing for fastening the bandage around the limb. The transmitter coils 54 are also lying flat on the skin and is considerably larger than the receiving coils on the stimulator. Due to the homogeneous electrical field and the size of same, the location of the transmitter coils on the limb is less significant.
The transmitter is operated by synchronous physiological signals e.g. suitably arranged switches or sensors. In case of a dropfoot patient by a heel switch or sensor. According to the present invention the receiving coil and the stimulating circuitry can be embedded in the wall of a nerve cuff electrode. The transmitting coil consists preferably of two flat coils, which are placed externally on each side of the implanted stimulator. The device will work at shorter distances with only a single transmitter coil.
The simple electronic circuitry combined with the use of very small, but standard electronic components (surface mount components), makes it possible to sufficiently reduce the size of the circuit for it to be embedded in the wall of a nerve cuff. Further the simple electronic circuitry makes it possible to avoid the need for her- metic packaging, which is necessary if the circuit contains naked silicon chips.
Integration of the stimulator into a nerve cuff makes the necessary stimulation current very low. This means that the range of an external transmitter can easily be made large enough for the implant to be located deep within an extremity.
The receiving coils of the implanted stimulators lie par- allel to the skin when implanted on a nerve, which makes it possible to use flat transmitting coils in the external transmitter. This is an advantage compared to other micro stimulators where the transmitting coil has to surround the implant. It means that the transmitting coil can easily be mounted on fabric and strapped onto/around the arm or leg with a velcro-closing or the like.
The use of two transmitting coils makes the range of the transmitter larger and the field more homogeneous, thus making the implanted stimulator less sensitive to movements with respect to the external transmitter. Accordingly, it is not significant that the transmitting coils are placed in the exact optimal position which can be difficult for the users who are typically disabled people who are paralysed in one side of their body
The lack of lead wires makes the device less susceptible to damage, since malfunction of an implanted device is often caused by broken wires. Also the risk of damage to the nerve in the chronic implant is reduced, since nerve damage is often a result of the wires pulling on the electrode. Also the lack of wires renders the device more simple to install.

Claims

1. An implantable stimulator electrode for stimulation of nerves adapted to be surgically implanted around a nerve bundle, said stimulator comprising a housing, preferably in the nature of a cuff, with one or more electrode means which, when implanted around said nerve bundle surrounds the nerve bundle totally or partly, electronic circuit means (2) with output terminals coupled to said electrode means, the electric circuit further comprising input terminals for receiving an input signal, c h a r a c t e r i s e d i n that the input terminals are coupled to one or more receiving coils (3) mounted on the stimulator housing.
2. An implantable stimulator according to claim 1, c h a r a c t e r i s e d i n that the electrode means, when implanted around said nerve bundle, com- prises one or more ring-shaped electrodes totally or partly surrounding the nerve bundle defining a contact area, each contact area being electrically coupled to the output terminals of the electronic circuit means.
3. An implantable stimulator according to claim 1 or 2, c h a r a c t e r i s e d i n that the electrode means, when implanted around said nerve bundle, comprises one or more ring-shaped electrodes totally or partly surrounding the nerve bundle, each ring-shaped electrode comprising at least two distinct electrode contact areas, each electrode area being electrically coupled to the output terminals of the electronic circuit means.
4. An implantable stimulator according to claim 2 or 3, c h a r a c t e r i s e d i n that the electrode means comprises three ring-shaped electrodes.
5. An implantable stimulator according to claim 1 to 4, c h a r a c t e r i s e d i n that the electronical circuit means comprises multi-channel pulse shaping electronics means, each input being coupled to a separate receiving coil, each output being coupled to a corresponding electrode contact area, said channels of said pulse shaping electronics means having a separate receiving frequency.
6. An implantable stimulator according to claim 1 to 5, c h a r a c t e r i s e d i n that the stimulator or a part of the stimulator are encapsulated within a biologically inert substance.
7. A transmitter-/receiver system comprising one or more transmitters and one or more implantable receiver stimulators according to claim 1 to 7, each transmitter comprising a control circuit, said control circuit controlling and activating a transmitting stage, said transmitting stage converting electric signals to electromagnetic signals, c h a r a c t e r i s e d i n that each transmitter comprises one or more transmitting coils positioned in spaced relationship on each side of one or more of the stimulators.
PCT/DK1998/000010 1997-01-13 1998-01-13 An implantable nerve stimulator electrode WO1998030279A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/331,838 US6366815B1 (en) 1997-01-13 1998-01-13 Implantable nerve stimulator electrode
AU54782/98A AU5478298A (en) 1997-01-13 1998-01-13 An implantable nerve stimulator electrode
DE69825969T DE69825969T2 (en) 1997-01-13 1998-01-13 IMPLANTABLE ELECTRODE FOR NERVE STIMULATION
AT98900271T ATE274974T1 (en) 1997-01-13 1998-01-13 IMPLANTABLE ELECTRODE FOR NERVE STIMULATION
EP98900271A EP0948373B1 (en) 1997-01-13 1998-01-13 An implantable nerve stimulator electrode

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0044/97 1997-01-13
DK4497 1997-01-13

Publications (1)

Publication Number Publication Date
WO1998030279A1 true WO1998030279A1 (en) 1998-07-16

Family

ID=8089099

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1998/000010 WO1998030279A1 (en) 1997-01-13 1998-01-13 An implantable nerve stimulator electrode

Country Status (6)

Country Link
US (1) US6366815B1 (en)
EP (1) EP0948373B1 (en)
AT (1) ATE274974T1 (en)
AU (1) AU5478298A (en)
DE (1) DE69825969T2 (en)
WO (1) WO1998030279A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2197535A1 (en) * 2007-10-09 2010-06-23 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US8055337B2 (en) 2008-07-24 2011-11-08 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8175711B2 (en) 2002-04-08 2012-05-08 Ardian, Inc. Methods for treating a condition or disease associated with cardio-renal function
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US6978174B2 (en) * 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US6990376B2 (en) * 2002-12-06 2006-01-24 The Regents Of The University Of California Methods and systems for selective control of bladder function
US20050111478A1 (en) * 2003-11-20 2005-05-26 International Business Machines Corporation Distributed control load shaping method and apparatus
US7450998B2 (en) * 2003-11-21 2008-11-11 Alfred E. Mann Foundation For Scientific Research Method of placing an implantable device proximate to neural/muscular tissue
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US20080255647A1 (en) * 2004-12-22 2008-10-16 Marc Jensen Implantable Addressable Segmented Electrodes
US20080077186A1 (en) * 2006-04-18 2008-03-27 Proteus Biomedical, Inc. High phrenic, low capture threshold pacing devices and methods
US7680538B2 (en) * 2005-03-31 2010-03-16 Case Western Reserve University Method of treating obstructive sleep apnea using electrical nerve stimulation
US7395119B2 (en) * 2005-05-19 2008-07-01 Cvrx, Inc. Implantable electrode assembly having reverse electrode configuration
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US8204586B2 (en) * 2005-11-22 2012-06-19 Proteus Biomedical, Inc. External continuous field tomography
FR2901988B1 (en) * 2006-06-09 2008-08-15 Universite De Grenoble 1 METHOD AND DEVICE FOR DETECTING AND PREVENTING PLANTARY ULCERS
US20080097566A1 (en) * 2006-07-13 2008-04-24 Olivier Colliou Focused segmented electrode
US20080039916A1 (en) * 2006-08-08 2008-02-14 Olivier Colliou Distally distributed multi-electrode lead
US9186511B2 (en) 2006-10-13 2015-11-17 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9744354B2 (en) 2008-12-31 2017-08-29 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9913982B2 (en) 2011-01-28 2018-03-13 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US7809442B2 (en) 2006-10-13 2010-10-05 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8855771B2 (en) 2011-01-28 2014-10-07 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US9205262B2 (en) 2011-05-12 2015-12-08 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US20080114230A1 (en) * 2006-11-14 2008-05-15 Bruce Addis Electrode support
CA2722982A1 (en) * 2008-05-02 2009-11-05 Medtronic, Inc. Self expanding electrode cuff
US8340785B2 (en) 2008-05-02 2012-12-25 Medtronic, Inc. Self expanding electrode cuff
WO2010039853A1 (en) * 2008-10-01 2010-04-08 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US8652129B2 (en) 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
JP2012521864A (en) 2009-03-31 2012-09-20 インスパイア・メディカル・システムズ・インコーポレイテッド Percutaneous access method in a system for treating sleep-related abnormal breathing
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US8805519B2 (en) 2010-09-30 2014-08-12 Nevro Corporation Systems and methods for detecting intrathecal penetration
JP6046041B2 (en) 2010-10-25 2016-12-14 メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ Devices, systems, and methods for neuromodulation therapy evaluation and feedback
US8934992B2 (en) 2011-09-01 2015-01-13 Inspire Medical Systems, Inc. Nerve cuff
EP2763743A4 (en) 2011-10-04 2015-08-05 Nevro Corp Modeling positions of implanted devices in a patient
US9750568B2 (en) 2012-03-08 2017-09-05 Medtronic Ardian Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
US9510777B2 (en) 2012-03-08 2016-12-06 Medtronic Ardian Luxembourg S.A.R.L. Monitoring of neuromodulation using biomarkers
US20140110296A1 (en) 2012-10-19 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
EP3104768B1 (en) 2014-02-11 2023-07-26 Cyberonics, Inc. Systems for detecting and treating obstructive sleep apnea
US10194979B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US10194980B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US9980766B1 (en) 2014-03-28 2018-05-29 Medtronic Ardian Luxembourg S.A.R.L. Methods and systems for renal neuromodulation
DE102014009136B4 (en) * 2014-06-18 2017-04-27 Forschungszentrum Jülich GmbH Housing for a medical implant
EP3535017A4 (en) 2016-11-04 2020-04-29 Galvani Bioelectronics Limited System for wirelessly coupling in vivo
US10980999B2 (en) 2017-03-09 2021-04-20 Nevro Corp. Paddle leads and delivery tools, and associated systems and methods
WO2019032890A1 (en) 2017-08-11 2019-02-14 Inspire Medical Systems, Inc. Cuff electrode
US11420045B2 (en) 2018-03-29 2022-08-23 Nevro Corp. Leads having sidewall openings, and associated systems and methods

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608985A (en) * 1984-10-11 1986-09-02 Case Western Reserve University Antidromic pulse generating wave form for collision blocking
US4932405A (en) * 1986-08-08 1990-06-12 Antwerp Bionic Systems N.V. System of stimulating at least one nerve and/or muscle fibre
GB2239802A (en) * 1990-01-09 1991-07-17 Univ Ottawa Transcutaneous energy transfer device
WO1992015366A1 (en) * 1991-03-11 1992-09-17 Case Western Reserve University Micturitional assist device
US5199428A (en) * 1991-03-22 1993-04-06 Medtronic, Inc. Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522811A (en) * 1969-02-13 1970-08-04 Medtronic Inc Implantable nerve stimulator and method of use
US3867950A (en) * 1971-06-18 1975-02-25 Univ Johns Hopkins Fixed rate rechargeable cardiac pacemaker
US4940065A (en) * 1989-01-23 1990-07-10 Regents Of The University Of California Surgically implantable peripheral nerve electrode
EP0529122B1 (en) * 1991-08-26 1995-11-08 Pacesetter AB Magnetic-field sensor
US5358514A (en) * 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608985A (en) * 1984-10-11 1986-09-02 Case Western Reserve University Antidromic pulse generating wave form for collision blocking
US4932405A (en) * 1986-08-08 1990-06-12 Antwerp Bionic Systems N.V. System of stimulating at least one nerve and/or muscle fibre
GB2239802A (en) * 1990-01-09 1991-07-17 Univ Ottawa Transcutaneous energy transfer device
WO1992015366A1 (en) * 1991-03-11 1992-09-17 Case Western Reserve University Micturitional assist device
US5199428A (en) * 1991-03-22 1993-04-06 Medtronic, Inc. Implantable electrical nerve stimulator/pacemaker with ischemia for decreasing cardiac workload

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2197535A1 (en) * 2007-10-09 2010-06-23 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
EP2197535A4 (en) * 2007-10-09 2013-08-21 Imthera Medical Inc Apparatus, system, and method for selective stimulation
US8055337B2 (en) 2008-07-24 2011-11-08 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources
US8131358B2 (en) 2008-07-24 2012-03-06 Boston Scientific Neuromodulation Corporation System and method for maintaining a distribution of currents in an electrode array using independent voltage sources

Also Published As

Publication number Publication date
ATE274974T1 (en) 2004-09-15
US6366815B1 (en) 2002-04-02
DE69825969T2 (en) 2005-01-20
EP0948373B1 (en) 2004-09-01
DE69825969D1 (en) 2004-10-07
EP0948373A1 (en) 1999-10-13
AU5478298A (en) 1998-08-03

Similar Documents

Publication Publication Date Title
EP0948373B1 (en) An implantable nerve stimulator electrode
US11679257B2 (en) Method of treating an overactive bladder condition
US10434320B2 (en) Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US5571148A (en) Implantable multichannel stimulator
US8498715B2 (en) Systems and methods for implantable leadless cochlear stimulation
US7899541B2 (en) Systems and methods for implantable leadless gastrointestinal tissue stimulation
US7894907B2 (en) Systems and methods for implantable leadless nerve stimulation
US4690144A (en) Wireless transcutaneous electrical tissue stimulator
US20070067000A1 (en) Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070060968A1 (en) Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070060955A1 (en) Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070060967A1 (en) Implantable pulse generator systems and methods for providing functional and /or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US11351389B2 (en) Charging-induced implant operation
DE60310130D1 (en) THERAPEUTIC SIGNALS DIRECTLY TRANSMITTING EXTERNALLY ACTIVATED NEUROIMPLANTATE
JPS5841570A (en) Muscle stimulating apparatus and method
WO2008080073A2 (en) Implantable neuromodulation system including wirelessly connected pulse generator and electrode array assembly
Schulman The feasible FES system: battery powered BION stimulator
CN111420281A (en) Cranial nerve regulator
CN212439710U (en) Cranial nerve regulator
US20200069207A1 (en) Neural Implant with Wireless Power Transfer
Kamal et al. Trans-receiver Type of Pacemaker

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1998900271

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09331838

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: CA

WWP Wipo information: published in national office

Ref document number: 1998900271

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1998900271

Country of ref document: EP